Brief: Pharmacyte Biotech Announces Preliminary Unaudited Financial Results For Fiscal Year 2022
11/07/2022 14:24
July 11 (Reuters) - PharmaCyte Biotech Inc PMCB.O :
* PHARMACYTE BIOTECH ANNOUNCES PRELIMINARY UNAUDITED
FINANCIAL
RESULTS FOR FISCAL YEAR 2022
* PHARMACYTE BIOTECH - NET LOSS FOR FY 2022 IS EXPECTED TO
BE
ABOUT $4.2 MILLION OR ABOUT $0.27 PER SHARE
Source text for Eikon: ID:nBw7q2Wmya
Further company coverage: PMCB.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Pharmacyte Biotech
See all newsBrief: Pharmacyte Biotech Inc - Increases Stake In Tnf Pharmaceuticals By $3 Million
Brief: PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease
Brief: Pharmacyte Biotech Acquires $5 Million Stake In Emerging Women’S Health Innovator Femasys
Brief: Femasys Inc. Secures Additional Financing With Strategic Investment From Investors Led By Pharmacyte Biotech
Brief: Pharmacyte Biotech Announces Final Results Of Tender Offer